Estradiol (E2) blood test: what it measures, normal levels by cycle phase and age, and what high or low estradiol means

Estradiol is the most potent of the three estrogens (estrone, estradiol and estriol) and the one that matters in women from puberty to menopause: it drives the growth of the uterine lining each cycle, triggers the LH surge that releases an egg, maintains bone density and affects skin, mood, sleep and the vessels. The test measures the concentration in blood, reported in pg/mL (some laboratories use pmol/L; multiply pg/mL by about 3.67). Most routine assays are immunoassays, which work well in the reproductive range; at the low levels seen in men, children and postmenopausal women they lose precision, and a mass-spectrometry (LC/MS) estradiol is the better test when those low values matter.

Because estradiol changes by the day within a cycle, the result only means something alongside the cycle day it was drawn on — and in women on hormonal contraception the ovaries are suppressed, so the measured level reflects the suppression rather than ovarian function (synthetic estrogens in the pill are not measured by an estradiol assay at all).

There is no single normal. Representative ranges from reference laboratories: in the early follicular phase (cycle days 2–5) roughly 20–150 pg/mL; mid-cycle, around ovulation, a peak of roughly 100–400 pg/mL; in the luteal phase roughly 50–250 pg/mL; after menopause below about 30 pg/mL (often under 10); in adult men about 10–40 pg/mL. Children before puberty are very low. Laboratories publish their own phase-specific ranges, and those apply to your report.

For fertility assessment the standard draw is cycle day 2–4, where estradiol is read together with FSH: a normal FSH with a high early-cycle estradiol can mask a declining ovarian reserve, because estradiol suppresses FSH — which is why the two are ordered as a pair. In pregnancy estradiol climbs steadily to very high levels and the test is rarely useful. In fertility treatment it is measured repeatedly to track follicle growth, where levels of several hundred to several thousand pg/mL are expected and interpreted by the clinic.

In women, 'high' depends entirely on the day — a mid-cycle peak of 350 pg/mL is normal and the same value on day 3 is not. Causes of a genuinely high level, from common to rare: a mistimed draw (the most frequent explanation); ovarian stimulation during fertility treatment; obesity, because fat tissue converts androgens to estrogen; estrogen-containing hormone therapy (bioidentical estradiol is measured by the assay, unlike the synthetic estrogen in most pills); the early perimenopause, when cycles become erratic and estradiol can spike; liver disease, which slows clearance; and, rarely, estrogen-producing ovarian or adrenal tumors, which usually present with heavy irregular bleeding or, in children, early puberty.

In men, elevated estradiol most often accompanies obesity and testosterone therapy (some injected testosterone is converted to estradiol, especially at peak levels), and less often liver disease, hyperthyroidism, or medications. Symptoms, when present, are breast tenderness or enlargement (gynecomastia), reduced libido and sometimes fluid retention; a high reading in a man with none of these is often an immunoassay artifact at the low end of the scale, and is confirmed with an LC/MS assay before anything is done about it.

Menopause is the expected cause: as the ovaries stop releasing eggs, estradiol falls and FSH rises, producing hot flashes, night sweats, vaginal dryness, sleep disruption and, over years, bone loss. The same low-estradiol picture before age 40 is primary ovarian insufficiency, confirmed by a high FSH on two occasions. Other causes: hypothalamic amenorrhea — periods stopping because of low body weight, intensive exercise, an eating disorder or severe stress, where FSH and LH are low rather than high; high prolactin; hypopituitarism; aromatase inhibitors used in breast cancer treatment; GnRH agonists; and, in both sexes, Turner syndrome and other developmental conditions. In men, low estradiol usually travels with low testosterone and is rarely measured on its own, though very low levels are associated with bone loss and increased fat.

The pattern of FSH and LH alongside estradiol tells the ovarian story: low estradiol with high FSH means the ovaries are not responding (menopause, ovarian insufficiency); low estradiol with low or normal FSH means the signal from the brain is reduced (hypothalamic causes, pituitary disease, high prolactin).

For a fertility baseline, draw on cycle day 2–4 with FSH (and often AMH, which can be drawn any day). To confirm ovulation, progesterone about seven days before the expected period is the better test; estradiol alone does not confirm that an egg was released. For menopause, guidelines generally diagnose it clinically — twelve months without a period at the typical age — and do not require hormone tests; estradiol and FSH are useful under 45, when the diagnosis is uncertain, or to investigate irregular bleeding. During menopausal hormone therapy, estradiol levels are not routinely needed to adjust oral or transdermal doses, which are titrated to symptoms, though some clinicians check them for patches or pellets. In men, estradiol is checked when gynecomastia or symptoms suggest excess, and on testosterone therapy when symptoms arise — ideally by LC/MS at the same point in the dosing cycle as the testosterone level.

Estradiol is not a useful test on combined hormonal contraception (the result reflects suppression), in pregnancy, or as a general 'hormone check' without a question attached.

Start with the cycle day and the medication list: a result read against the wrong phase, or drawn on hormonal contraception or hormone therapy, is the most common 'abnormal' estradiol and is simply reinterpreted. If the timing was right, the next step is to read it with its companions — FSH and LH for the pattern, prolactin and TSH for the common secondary causes, progesterone to confirm ovulation, and total testosterone in men — and to repeat it in the right phase of the next cycle if the picture is unclear. Persistently low estradiol in a woman under 45 with absent periods, a high level with heavy irregular bleeding, or any level with breast enlargement in a man, is a reason to see a clinician, who may add pelvic ultrasound, an LC/MS assay or pituitary testing. Bone density becomes a consideration whenever estradiol has been low for more than a year or two.

Estradiol is a routine hormone test at Quest and Labcorp, available through a clinician or directly through TestWell with physician review; results post in a few business days. No fasting is needed, but the cycle day is everything: for a fertility baseline schedule the draw for cycle day 2–4 with FSH, and record the day for whoever reads it. Postmenopausal women and men should ask for the LC/MS (mass spectrometry) estradiol when low values matter, since immunoassays are imprecise at that end. Biotin supplements can interfere with some hormone immunoassays; stop them for two days before the draw.